Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Liabilities and Shareholders Equity: 2020-2021

Historic Liabilities and Shareholders Equity for Design Therapeutics (DSGN) over the last 1 years, with Sep 2021 value amounting to $400.4 million.

  • Design Therapeutics' Liabilities and Shareholders Equity was N/A to $400.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.3 billion, marking a year-over-year change of. This contributed to the annual value of $36.5 million for FY2020, which is N/A change from last year.
  • As of Q3 2021, Design Therapeutics' Liabilities and Shareholders Equity stood at $400.4 million, which was down 1.18% from $405.1 million recorded in Q2 2021.
  • Design Therapeutics' Liabilities and Shareholders Equity's 5-year high stood at $411.9 million during Q1 2021, with a 5-year trough of $36.5 million in Q4 2020.
  • Moreover, its 2-year median value for Liabilities and Shareholders Equity was $402.7 million (2021), whereas its average is $313.5 million.